Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and B-Cell Lymphoma

n-methyl-3,4-methylenedioxyamphetamine has been researched along with B-Cell Lymphoma in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meredith, EJ1
Holder, MJ1
Chamba, A1
Challa, A1
Drake-Lee, A1
Bunce, CM1
Drayson, MT1
Pilkington, G1
Blakely, RD1
Dyer, MJ1
Barnes, NM1
Gordon, J1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and B-Cell Lymphoma

ArticleYear
The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2005, Volume: 19, Issue:9

    Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Burkitt L

2005